Bio-Techne vs NetSuite
Side-by-side comparison of AI visibility scores, market position, and capabilities
Minneapolis life science tools (NASDAQ: TECH) at $1.19B FY2024 revenue; Q2 FY2025 9% organic growth, R&D Systems cytokines/antibodies + RNAscope spatial biology (500K+ products) competing with Thermo Fisher for biopharma reagents.
About
Bio-Techne Corporation is a Minneapolis, Minnesota-based life sciences tools company — publicly traded on NASDAQ (NASDAQ: TECH) as an S&P 500 Health Care component — developing, manufacturing, and selling biological reagents, proteins, antibodies, assay kits, analytical instruments, and spatial biology tools for pharmaceutical drug discovery, bioprocessing, academic research, and clinical diagnostics through approximately 3,000 employees across 34 global locations with an annual revenue of $1.19 billion in fiscal year 2024. In Q2 fiscal 2025, Bio-Techne reported organic revenue growth of 9% to $297 million, demonstrating recovery from the funding-constrained biotech environment of 2023-2024. The company operates through two segments: Protein Sciences (approximately 75% of revenue, including the R&D Systems portfolio of 500,000+ life science products — cytokines, growth factors, antibodies, ELISAs, and recombinant proteins — as well as ProteinSimple analytical instruments and Tocris Bioscience chemical biology tools) and Diagnostics and Genomics (approximately 25%, including Advanced Cell Diagnostics' RNAscope technology for gene expression visualization in intact tissue and Lunaphore's COMET spatial biology automation platform acquired in 2023). Bio-Techne launched approximately 800 new products in fiscal 2024 and maintains a catalog of 6,000+ recombinant proteins spanning 35 species. The company has a market capitalization of approximately $9.59 billion.
Oracle Corporation's cloud ERP for SMBs (40,000+ customers, 219 countries); NetSuite Next's Ask Oracle natural language AI assistant (SuiteWorld 2025), single-platform financial/CRM/inventory competing with SAP Business One.
About
NetSuite is a San Mateo, California and Austin, Texas-based cloud enterprise resource planning (ERP) platform and business unit of Oracle Corporation (NYSE: ORCL) — serving over 40,000 customers in 219 countries and territories with cloud-native financial management, CRM, inventory, supply chain, human capital management, and e-commerce applications designed for small-to-midsize businesses and rapidly growing enterprises that need unified business management software from a single cloud platform. NetSuite was founded in 1998 as NetLedger (one of the world's first cloud-based ERP systems) and acquired by Oracle in 2016 for $9.3 billion. Oracle's platform integration — connecting NetSuite to Oracle Cloud Infrastructure (OCI), Oracle Analytics Cloud, and Oracle's AI layer — enables NetSuite to leverage hyperscale compute, data warehousing, and generative AI capabilities that independent ERP vendors cannot build at equivalent cost. At SuiteWorld 2025, NetSuite unveiled NetSuite Next, featuring Ask Oracle — a natural language AI assistant enabling business users to search records, navigate workflows, analyze financial data, and trigger business actions across the entire NetSuite dataset through conversational queries rather than menu navigation — advancing toward autonomous AI-driven business management. The Oracle leadership transition (co-CEOs Clay Magouyrk and Mike Sicilia replacing Safra Catz) underscores Oracle's commitment to accelerating cloud product innovation across NetSuite, Oracle Cloud ERP (Fusion), and Oracle's SaaS portfolio.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.